Shared Content Block:
Surgery Styles -- prevent images from going 100% wide on mobile
During this time of gratitude we are thankful to have the opportunity to work with each of you!
Dr. Vogel is a board-certified colorectal surgeon with an interest in the surgical treatment of inflammatory bowel disease. His previous clinical research has covered a variety of surgical topics including ones that have been focused on surgical techniques, surgical site infection, and perioperative variables. Most of this research has been via retrospective analysis of databases or medical records and has led to several peer-reviewed journal publications. During his surgical residency, he spent 2 years as a member of a basic science research group and participated in projects that were focused on cytokine production by intestinal epithelial cells. That experience furnished Dr. Vogel with a lasting appreciation for the scientific method. More recently, his commitment to surgical research has expanded. In 2018, he was the recipient of grant funding in the amount of $100,000 to lead a multicenter prospective study. In this study, the primary aim is to determine the safety of early ileostomy reversal after ileal pouch surgery. Since receiving this award, and going through the long process that began with an idea and has now reached a point where study enrollment has begun, Dr. Vogel states, "I have learned a tremendous amount about organizing a multicenter prospective trial. I am now enthusiastic about the opportunity to lead a 2nd multicenter prospective trial that has the potential to improve the surgical outcomes of malnourished Crohn's disease patients who require intestinal surgery. I work at a university-based, academic Surgery Department, with extensive resources that are available to assist in both the organization and completion of a high-quality multicenter trial."
Dr. Vogel's study is titled: The Short versus Long interval to loop Ileostomy Reversal after ileal Pouch Surgery in patients with ulcerative colitis trial (SLIRPS Trial)
Congratulations, Dr. Vogel, on enrolling your first patient!
Chloe is the database coordinator in the Clinical Research and Trials Unit for the Division of Surgical Oncology. She joined the department in June 2017 and manages the division's databases and performs statistical analyses using institutional and national datasets. The research projects she works on primarily study surgical outcomes and national practice patterns. Prior to joining the Department of Surgery, Chloe received a Master of Public Health in Epidemiology from Columbia University Mailman School of Public Health in 2017, with a certificate in the Epidemiology of Chronic Disease, and a Bachelor of Science in Biology from Emory University in 2015.
Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers. Torphy RJ, Friedman C, Halpern A, Chapman BC, Ahrendt SS, McCarter MM, Edil BH, Schulick RD, Gleisner A. Ann Surg, 2018 May 16.
Phase 2 Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Evaluate The Safety and Efficacy of Reltecimod as Compared to Placebo in Addition to Standard of Care in Patients with Sepsis-associated Acute Kidney Injury (SA-AKI)
A Randomized, Double-Blinded, Controlled, Parallel Group, Non-inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients undergoing Complex Cardiac Surgery Procedures (the ReCePI study)
A Prospective, Multicenter, Non-Blinded, Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects with an Acute, Complicated Type B Aortic Dissection